Research Article
A Noval Established Cuproptosis-Associated LncRNA Signature for Prognosis Prediction in Primary Hepatic Carcinoma
Figure 7
Different expression of (a) FDX1, (b) CDKN2A, (c) GLS, and (d) MTF1 in the high- and low-risk groups.
| (a) |
| (b) |
| (c) |
| (d) |